1999•Chinese Journal of Cancer ResearchRequires access

Relationship among PS2 protein expression, estrogen and progesterone receptor status, and prognosis of breast cancer

Jingxian Liu, Jiyou Li, He Luowen, Zhao Yajuan

Open publisher page 0 citations

Abstract

Objective: To study the relationship between the expression of PS 2 protein and Estrogen (ER) and Progesterone Receptor (PR) status and their prognotic value in breast cancer. Methods: Using the immunohistochemical method, PS 2 protein expressions were detected in 105 cases with breast cancer. Results: The positive rate of PS 2 protein was 50.48% (53/105) in 105 cases. The positive rate of PS 2 in the patients who survived five years or more was 56.96% (45/79), which was higher than that of those who lived less than five years (30.77%, 8/26). In the ER, PR (+) patients, the positive rate of PS 2 was higher (76.74%, 33/34), than that of those with ER, PR (−) (22.5%, 9/40). Conclusions: Our results suggest that the expression of PS 2 protein was positively correlated with the 5-year-survival and that of ER and PR in breast cancer. It is considered that PS 2 may be as a prognostic predictor, and detection of PS 2 protein expression was useful for a guiding treatment of breast cancer.

About this research paper

What this paper is about

Objective: To study the relationship between the expression of PS 2 protein and Estrogen (ER) and Progesterone Receptor (PR) status and their prognotic value in breast cancer. Methods: Using the immunohistochemical method, PS 2 protein expressions were detected in 105 cases with breast cancer. Results: The positive rate of PS 2 protein was 50.48% (53/105) in 105 cases. The positive rate of PS 2 in the patients who survived five years or more was 56.96% (45/79), which was higher than that of those who lived less than five years (30.77%, 8/26). In the ER, PR (+) patients, the positive rate of PS 2 was higher (76.74%, 33/34), than that of those with ER, PR (−) (22.5%, 9/40). Conclusions: Our results suggest that the expression of PS 2 protein was positively correlated with the 5-year-survival and that of ER and PR in breast cancer. It is considered that PS 2 may be as a prognostic predictor, and detection of PS 2 protein expression was useful for a guiding treatment of breast cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study the relationship between the expression of PS 2 protein and Estrogen (ER) and Progesterone Receptor (PR) status and their prognotic value in breast cancer. Methods: Using the immunohistochemical method, PS 2 protein expressions were detected in 105 cases with breast cancer. Results: The positive rate of PS 2 protein was 50.48% (53/105) in 105 cases. The positive rate of PS 2 in the patients who survived five years or more was 56.96% (45/79), which was higher than that of those who lived less than five years (30.77%, 8/26). In the ER, PR (+) patients, the positive rate of PS 2 was higher (76.74%, 33/34), than that of those with ER, PR (−) (22.5%, 9/40). Conclusions: Our results suggest that the expression of PS 2 protein was positively correlated with the 5-year-survival and that of ER and PR in breast cancer. It is considered that PS 2 may be as a prognostic predictor, and detection of PS 2 protein expression was useful for a guiding treatment of breast cancer.

Key concepts: Breast cancer, Progesterone receptor, Immunohistochemistry, Estrogen receptor, Medicine, Internal medicine, Estrogen, Protein expression

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship among PS2 protein expression, estrogen and progesterone receptor status, and prognosis of breast cancer — Research Paper | ScholarLens